Clinical Trials Browser

Phase 1 × Solid Neoplasm × pazopanib × Clear all

NCT01552356 2026-03-18

Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors

Phase 1 Active not recruiting

Solid Neoplasm